<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35902632</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope.</ArticleTitle><Pagination><StartPage>751</StartPage><MedlinePgn>751</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">751</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-022-03717-x</ELocationID><Abstract><AbstractText>The HLA-DRB1*03:01 allele is a major genetic risk factor in systemic lupus erythematosus (SLE), but the mechanistic basis of the association is unclear. Here we show that in the presence of interferon gamma (IFN-&#x3b3;), a short DRB1*03:01-encoded allelic epitope activates a characteristic lupus transcriptome in mouse and human macrophages. It also triggers a cascade of SLE-associated cellular aberrations, including endoplasmic reticulum stress, unfolded protein response, mitochondrial dysfunction, necroptotic cell death, and production of pro-inflammatory cytokines. Parenteral administration of IFN-&#x3b3; to na&#xef;ve DRB1*03:01 transgenic mice causes increased serum levels of anti-double stranded DNA antibodies, glomerular immune complex deposition and histopathological renal changes that resemble human lupus nephritis. This study provides evidence for a noncanonical, antigen presentation-independent mechanism of HLA-disease association in SLE and could lay new foundations for our understanding of key molecular mechanisms that trigger and propagate this devastating autoimmune disease.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Miglioranza Scavuzzi</LastName><ForeName>Bruna</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9609-001X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>van Drongelen</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2090-7617</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Bhavneet</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Jennifer Callahan</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jianhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesquita-Ferrari</LastName><ForeName>Raquel A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahlenberg</LastName><ForeName>J Michelle</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-4006-8945</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farkash</LastName><ForeName>Evan A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-5136-079X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benavides</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Epigenetics and Molecular Carcinogenesis, MD Anderson Cancer Center, Houston, TX, 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Frederick W</ForeName><Initials>FW</Initials><Identifier Source="ORCID">0000-0003-2831-9593</Identifier><AffiliationInfo><Affiliation>Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawalha</LastName><ForeName>Amr H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Pediatrics and Internal Medicine, University of Pittsburgh, Pittsburgh, PA, 15224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holoshitz</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6563-0404</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA. jholo@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R33 AR073014</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007080</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R61 AR073014</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR074930</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN273201600123P</GrantID><Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS)</Agency><Country/></Grant><Grant><GrantID>R01 AR059085</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Rheumatol. 2022 Oct;18(10):552</RefSource><PMID Version="1">36068355</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.H. is consulting to Zydus-Cadila, a Licensee of unrelated patents owned by the Regents of the University of Michigan. J.M.K has received grant funding from Q32 Bio, Janssen, Bristol Myers Squibb, and ROME Therapeutics, and Ventus Therapeutics. She has done consulting work for Bristol Myers Squibb, Eli Lilly, GlaxoSmithKlein, Gilead, Aurinia Pharmaceuticals, AstraZeneca, and Lupus Therapeutics. All other authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35902632</ArticleId><ArticleId IdType="pmc">PMC9334592</ArticleId><ArticleId IdType="doi">10.1038/s42003-022-03717-x</ArticleId><ArticleId IdType="pii">10.1038/s42003-022-03717-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic Lupus Erythematosus. N. Engl. J. Med. 2011;365:2110&#x2013;2121. doi: 10.1056/NEJMra1100359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A, Gergely P, Jr, Nagy G, Koncz A, Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 2004;25:360&#x2013;367. doi: 10.1016/j.it.2004.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.05.001</ArticleId><ArticleId IdType="pmc">PMC4034110</ArticleId><ArticleId IdType="pubmed">15207503</ArticleId></ArticleIdList></Reference><Reference><Citation>Navid F, Colbert R. Causes and consequences of endoplasmic reticulum stress in rheumatic disease. Nat. Rev. Rheumatol. 2017;13:25&#x2013;40. doi: 10.1038/nrrheum.2016.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.192</ArticleId><ArticleId IdType="pubmed">27904144</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat. Rev. Rheumatol. 2016;12:716&#x2013;730. doi: 10.1038/nrrheum.2016.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y-F, et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat. Commun. 2021;12:772. doi: 10.1038/s41467-021-21049-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21049-y</ArticleId><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, et al. Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus. Ann. Rheum. Dis. 2020;80:632&#x2013;640. doi: 10.1136/annrheumdis-2020-219209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219209</ArticleId><ArticleId IdType="pmc">PMC8053352</ArticleId><ArticleId IdType="pubmed">33272962</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcellos LF, et al. High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet. 2009;5:1&#x2013;10. doi: 10.1371/journal.pgen.1000696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000696</ArticleId><ArticleId IdType="pmc">PMC2758598</ArticleId><ArticleId IdType="pubmed">19851445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodke-Puranik Y, Niewold TB. Immunogenetics of systemic lupus erythematosus: A comprehensive review. J. Autoimmun. 2015;64:125&#x2013;136. doi: 10.1016/j.jaut.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4628859</ArticleId><ArticleId IdType="pubmed">26324017</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, et al. Unraveling Multiple MHC Gene Associations with Systemic Lupus Erythematosus: Model Choice Indicates a Role for HLA Alleles and Non-HLA Genes in Europeans. Am. J. Hum. Genet. 2012;91:778&#x2013;793. doi: 10.1016/j.ajhg.2012.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.08.026</ArticleId><ArticleId IdType="pmc">PMC3487133</ArticleId><ArticleId IdType="pubmed">23084292</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida DED, Holoshitz J. MHC molecules in health and disease: At the cusp of a paradigm shift. Self Nonself. 2011;2:43&#x2013;48. doi: 10.4161/self.2.1.15757.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/self.2.1.15757</ArticleId><ArticleId IdType="pmc">PMC3136903</ArticleId><ArticleId IdType="pubmed">21776334</ArticleId></ArticleIdList></Reference><Reference><Citation>Holoshitz J. The Quest for Better Understanding of HLA-Disease Association: Scenes from a Road Less Travelled By. Disco. Med. 2013;16:93&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4064294</ArticleId><ArticleId IdType="pubmed">23998445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills CD. M1 and M2 Macrophages: Oracles of Health and Disease. Crit. Rev. Immunol. 2012;32:463&#x2013;488. doi: 10.1615/CritRevImmunol.v32.i6.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v32.i6.10</ArticleId><ArticleId IdType="pubmed">23428224</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Yang Y, Zhu X, Huang L, Xu J. Macrophage Polarization Modulates Development of Systemic Lupus Erythematosus. Cell Physiol. Biochem. 2015;37:1279&#x2013;1288. doi: 10.1159/000430251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000430251</ArticleId><ArticleId IdType="pubmed">26431544</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Kaplan MJ. Cardiovascular disease in systemic lupus erythematosus: an update. Curr. Opin. Rheumatol. 2018;30:441&#x2013;448. doi: 10.1097/BOR.0000000000000528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000528</ArticleId><ArticleId IdType="pubmed">29870498</ArticleId></ArticleIdList></Reference><Reference><Citation>Karonitsch T, et al. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum. 2009;60:1463&#x2013;1471. doi: 10.1002/art.24449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24449</ArticleId><ArticleId IdType="pubmed">19404947</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 1997;99:1936&#x2013;1946. doi: 10.1172/JCI119361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI119361</ArticleId><ArticleId IdType="pmc">PMC508018</ArticleId><ArticleId IdType="pubmed">9109438</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrier N, et al. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Arthritis Rheum. 2009;60:698&#x2013;707. doi: 10.1002/art.24353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24353</ArticleId><ArticleId IdType="pubmed">19248090</ArticleId></ArticleIdList></Reference><Reference><Citation>Woude Dvd, et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum. 2010;62:1236&#x2013;1245. doi: 10.1002/art.27366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.27366</ArticleId><ArticleId IdType="pubmed">20131291</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa H, et al. The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases. Genes Immun. 2017;18:1&#x2013;7. doi: 10.1038/gene.2016.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2016.40</ArticleId><ArticleId IdType="pubmed">27829665</ArticleId></ArticleIdList></Reference><Reference><Citation>Drongelen VV, et al. HLA-DRB1 allelic epitopes that associate with autoimmune disease risk or protection activate reciprocal macrophage polarization. Sci. Rep. 2021;11:1&#x2013;15. doi: 10.1038/s41598-020-79139-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79139-8</ArticleId><ArticleId IdType="pmc">PMC7844024</ArticleId><ArticleId IdType="pubmed">33510427</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205&#x2013;1213. doi: 10.1002/art.1780301102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780301102</ArticleId><ArticleId IdType="pubmed">2446635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton JJ, Latham K, Beattie RM, Ennis S. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Aliment Pharm. Ther. 2019;50:885&#x2013;900. doi: 10.1111/apt.15485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15485</ArticleId><ArticleId IdType="pubmed">31518029</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble JA, et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 1996;59:1134&#x2013;1148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1914851</ArticleId><ArticleId IdType="pubmed">8900244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong YC, et al. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med. 1996;184:1167&#x2013;1172. doi: 10.1084/jem.184.3.1167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.3.1167</ArticleId><ArticleId IdType="pmc">PMC2192804</ArticleId><ArticleId IdType="pubmed">9064334</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibault DL, et al. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Invest. 2008;118:1417&#x2013;1426. doi: 10.1172/JCI30065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI30065</ArticleId><ArticleId IdType="pmc">PMC2267033</ArticleId><ArticleId IdType="pubmed">18340381</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat. Immunol. 2019;20:1574&#x2013;1583. doi: 10.1038/s41590-019-0466-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0466-2</ArticleId><ArticleId IdType="pmc">PMC7024546</ArticleId><ArticleId IdType="pubmed">31745335</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, et al. Identification of Regulatory Modules That Stratify Lupus Disease Mechanism through Integrating Multi-Omics Data. Mol. Ther. - Nucleic Acids. 2020;19:318&#x2013;329. doi: 10.1016/j.omtn.2019.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.11.019</ArticleId><ArticleId IdType="pmc">PMC6938958</ArticleId><ArticleId IdType="pubmed">31877408</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubert K, et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat. Med. 2008;14:748&#x2013;755. doi: 10.1038/nm1763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1763</ArticleId><ArticleId IdType="pubmed">18542049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WS, et al. A pathogenic role for ER stress&#x2010;induced autophagy and ER chaperone GRP78/BiP in T lymphocyte systemic lupus erythematosus. J. Leukoc. Biol. 2014;97:425&#x2013;433. doi: 10.1189/jlb.6A0214-097R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.6A0214-097R</ArticleId><ArticleId IdType="pubmed">25516752</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca FJ, Whitworth LJ, Redmond S, Jones AA, Ramakrishnan L. TNF Induces Pathogenic Programmed Macrophage Necrosis in Tuberculosis through a Mitochondrial-Lysosomal-Endoplasmic Reticulum Circuit. Cell. 2019;178:1344&#x2013;1361. doi: 10.1016/j.cell.2019.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.004</ArticleId><ArticleId IdType="pmc">PMC6736209</ArticleId><ArticleId IdType="pubmed">31474371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, et al. Endoplasmic reticulum-associated degradation regulates mitochondrial dynamics in brown adipocytes. Science. 2020;368:54&#x2013;60. doi: 10.1126/science.aay2494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay2494</ArticleId><ArticleId IdType="pmc">PMC7409365</ArticleId><ArticleId IdType="pubmed">32193362</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D, et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat. Rev. Drug Disco. 2017;17:843&#x2013;862. doi: 10.1038/nrd.2017.201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.201</ArticleId><ArticleId IdType="pubmed">29104284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedlackova L, Korolchuk VI. Mitochondrial quality control as a key determinant of cell survival. Biochim Biophys. Acta Mol. Cell Res. 2019;1866:575&#x2013;587. doi: 10.1016/j.bbamcr.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2018.12.012</ArticleId><ArticleId IdType="pubmed">30594496</ArticleId></ArticleIdList></Reference><Reference><Citation>Locatelli, S. L. et al. Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation. Sci Rep6, 35745 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5073341</ArticleId><ArticleId IdType="pubmed">27767172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin. Immunol. 2017;185:59&#x2013;73. doi: 10.1016/j.clim.2016.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.08.010</ArticleId><ArticleId IdType="pmc">PMC5299061</ArticleId><ArticleId IdType="pubmed">27519955</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell BD, et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl Acad. Sci. USA. 2008;105:16677&#x2013;16682. doi: 10.1073/pnas.0808597105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0808597105</ArticleId><ArticleId IdType="pmc">PMC2575479</ArticleId><ArticleId IdType="pubmed">18946037</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 2014;15:135&#x2013;147. doi: 10.1038/nrm3737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3737</ArticleId><ArticleId IdType="pubmed">24452471</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, et al. Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus. Cell Death Dis. 2014;5:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4225223</ArticleId><ArticleId IdType="pubmed">25210799</ArticleId></ArticleIdList></Reference><Reference><Citation>Senft D, Ronai ZeA. UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. 2015;40:141&#x2013;148. doi: 10.1016/j.tibs.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.01.002</ArticleId><ArticleId IdType="pmc">PMC4340752</ArticleId><ArticleId IdType="pubmed">25656104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordaliza&#x2010;Alaguero I, Cant&#xf3; C, Zorzano A. Metabolic implications of organelle&#x2013;mitochondria communication. EMBO Rep. 2019;20:e47928. doi: 10.15252/embr.201947928.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201947928</ArticleId><ArticleId IdType="pmc">PMC6726909</ArticleId><ArticleId IdType="pubmed">31418169</ArticleId></ArticleIdList></Reference><Reference><Citation>Namgaladze D, Khodzhaeva V, Br&#xfc;ne B. ER-Mitochondria Communication in Cells of the Innate Immune System. Cells. 2019;8:1&#x2013;21. doi: 10.3390/cells8091088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091088</ArticleId><ArticleId IdType="pmc">PMC6770024</ArticleId><ArticleId IdType="pubmed">31540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota K, et al. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. J. Neurochem. 2006;97:1259&#x2013;1268. doi: 10.1111/j.1471-4159.2006.03782.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03782.x</ArticleId><ArticleId IdType="pubmed">16539653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnemaison M, Marks-Nelson E, Boesen E. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice. Clin. Sci. (Lond.) 2019;133:167&#x2013;180. doi: 10.1042/CS20180562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180562</ArticleId><ArticleId IdType="pubmed">30617186</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Jung J, Lee E, Kim K, Yoo W. 4-phenylbutyric acid mediates therapeutic effect in systemic lupus erythematosus: Observations in an experimental murine lupus model. Exp. Ther. Med. 2021;21:1&#x2013;9. doi: 10.3892/etm.2021.9891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.9891</ArticleId><ArticleId IdType="pmc">PMC7967889</ArticleId><ArticleId IdType="pubmed">33747192</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl, J. et al. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J. Exp. Med.218, 138 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8020718</ArticleId><ArticleId IdType="pubmed">33783474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisirak V, et al. Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity. Cell. 2016;166:88&#x2013;101. doi: 10.1016/j.cell.2016.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.034</ArticleId><ArticleId IdType="pmc">PMC5030815</ArticleId><ArticleId IdType="pubmed">27293190</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mayouf S, et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 2011;43:1186&#x2013;1188. doi: 10.1038/ng.975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.975</ArticleId><ArticleId IdType="pubmed">22019780</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J. Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum. Immunol. 1987;19:155&#x2013;162. doi: 10.1016/0198-8859(87)90066-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0198-8859(87)90066-8</ArticleId><ArticleId IdType="pubmed">3305436</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#x11b;&#x161;ick&#xfd; M, Vinkler M. Trans-Species Polymorphism in Immune Genes: General Pattern or MHC-Restricted Phenomenon? J. Immunol. Res. 2015;2015:1&#x2013;10. doi: 10.1155/2015/838035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/838035</ArticleId><ArticleId IdType="pmc">PMC4458282</ArticleId><ArticleId IdType="pubmed">26090501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert PH, Dixon FJ. Pathogenesis of the glomerulonephritis of NZB/W mice. J. Exp. Med. 1968;127:507&#x2013;522. doi: 10.1084/jem.127.3.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.127.3.507</ArticleId><ArticleId IdType="pmc">PMC2138462</ArticleId><ArticleId IdType="pubmed">4169964</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusbaum JS, et al. Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. Mayo Clin. Proc. 2020;95:384&#x2013;394. doi: 10.1016/j.mayocp.2019.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2019.09.012</ArticleId><ArticleId IdType="pubmed">32029091</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 2017;8:1&#x2013;18. doi: 10.1038/ncomms16021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16021</ArticleId><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachopoulou E, et al. Evaluation of HLA-DRB1 imputation using a Finnish dataset. Tissue Antigens. 2014;83:350&#x2013;355. doi: 10.1111/tan.12343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.12343</ArticleId><ArticleId IdType="pubmed">24666112</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas DJ, et al. Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest. Pharmacogenomics J. 2018;18:367&#x2013;376. doi: 10.1038/tpj.2017.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tpj.2017.7</ArticleId><ArticleId IdType="pmc">PMC5656547</ArticleId><ArticleId IdType="pubmed">28440342</ArticleId></ArticleIdList></Reference><Reference><Citation>Drongelen VV, Ali WH, Holoshitz J. Uncovering a Shared Epitope-Activated Protein Citrullination Pathway. J. Immunol. 2020;205:579&#x2013;586. doi: 10.4049/jimmunol.1901108.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1901108</ArticleId><ArticleId IdType="pmc">PMC7372319</ArticleId><ArticleId IdType="pubmed">32591395</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj P, et al. Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife. 2016;5:1&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4811771</ArticleId><ArticleId IdType="pubmed">26880555</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan S, Trejo T, Hansen J, Smart M, David CS. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. J. Immunol. 1998;161:2925&#x2013;2929.</Citation><ArticleIdList><ArticleId IdType="pubmed">9743354</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja V, et al. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J. Immunol. 2003;171:4431&#x2013;4438. doi: 10.4049/jimmunol.171.8.4431.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.8.4431</ArticleId><ArticleId IdType="pubmed">14530370</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss G, Vignali D, Sch&#xf6;nrich G, H&#xe4;mmerling G. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics. 1994;40:104&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">8026858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigmon J, et al. Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research. Genetics. 2020;216:905&#x2013;930. doi: 10.1534/genetics.120.303596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.120.303596</ArticleId><ArticleId IdType="pmc">PMC7768238</ArticleId><ArticleId IdType="pubmed">33067325</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigneault M, Preston JA, Marriott HM, Whyte MKB, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010;5:1&#x2013;10. doi: 10.1371/journal.pone.0008668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008668</ArticleId><ArticleId IdType="pmc">PMC2800192</ArticleId><ArticleId IdType="pubmed">20084270</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44&#x2013;57. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Babicki S, et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 2016;44:147&#x2013;153. doi: 10.1093/nar/gkw419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw419</ArticleId><ArticleId IdType="pmc">PMC4987948</ArticleId><ArticleId IdType="pubmed">27190236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan, S. &amp; Draghici, S. Identifying Significantly Impacted Pathways and Putative Mechanisms with iPathwayGuide. Curr Protoc Bioinformatics, 7.15.11&#x2013;17.15.30, (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28654712</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan FK-M, Moriwaki K, Rosa MJD. Detection of Necrosis by Release of Lactate Dehydrogenase (LDH) Activity. Methods Mol. Biol. 2013;979:65&#x2013;70. doi: 10.1007/978-1-62703-290-2_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-290-2_7</ArticleId><ArticleId IdType="pmc">PMC3763497</ArticleId><ArticleId IdType="pubmed">23397389</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;ster K, Horstkorte R. Enzymatic quantification of cell&#x2013;matrix and cell&#x2013;cell adhesion. Micron. 2000;31:41&#x2013;53. doi: 10.1016/S0968-4328(99)00062-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-4328(99)00062-1</ArticleId><ArticleId IdType="pubmed">10568230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55&#x2013;63. doi: 10.1016/0022-1759(83)90303-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(83)90303-4</ArticleId><ArticleId IdType="pubmed">6606682</ArticleId></ArticleIdList></Reference><Reference><Citation>Olive PL, Ban&#xe1;th JP. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 2006;1:23&#x2013;29. doi: 10.1038/nprot.2006.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.5</ArticleId><ArticleId IdType="pubmed">17406208</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins AR. The comet assay for DNA damage and repair. Mol. Biotechnol. 2004;26:249&#x2013;261. doi: 10.1385/MB:26:3:249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/MB:26:3:249</ArticleId><ArticleId IdType="pubmed">15004294</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohraff DM, et al. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice. Arthritis Rheumatol. 2019;71:1681&#x2013;1690. doi: 10.1002/art.40931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40931</ArticleId><ArticleId IdType="pmc">PMC6764871</ArticleId><ArticleId IdType="pubmed">31106974</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar, R., Domrachev, M. &amp; Lash, A. in Nucleic Acids Res30, 207&#x2013;210 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99122</ArticleId><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>